SLC9A1 and heart failure: A recent study by Pan et al. (2024) demonstrated that puerarin acts as an effective anti-heart failure agent by inhibiting p38 mitogen-activated protein kinase and its downstream effector NHE1 (sodium-hydrogen exchanger 1).